UiPath (NYSE:PATH) Shares Down 0.4%

UiPath Inc. (NYSE:PATH - Get Free Report)'s share price traded down 0.4% during trading on Thursday . The company traded as low as $18.88 and last traded at $19.17. 1,064,808 shares traded hands during trading, a decline of 87% from the average session volume of 8,476,149 shares. The stock had previously closed at $19.24.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Truist Financial reiterated a "buy" rating and set a $32.00 price target on shares of UiPath in a report on Wednesday, March 20th. Needham & Company LLC restated a "buy" rating and set a $30.00 price objective on shares of UiPath in a report on Wednesday, March 20th. Canaccord Genuity Group boosted their price objective on UiPath from $27.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, March 15th. BMO Capital Markets lifted their price target on shares of UiPath from $24.00 to $28.00 and gave the company a "market perform" rating in a research report on Thursday, March 14th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $29.00 price target on shares of UiPath in a research report on Monday, April 1st. Nine equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $27.41.

UiPath Price Performance

The firm has a market capitalization of $10.97 billion, a price-to-earnings ratio of -112.88 and a beta of 1.01. The firm's 50-day simple moving average is $21.91 and its 200 day simple moving average is $21.65.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. As a group, research analysts predict that UiPath Inc. will post -0.04 earnings per share for the current year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of the company's stock in a transaction on Monday, February 5th. The shares were sold at an average price of $22.47, for a total transaction of $359,520.00. Following the completion of the transaction, the chief financial officer now directly owns 103,505 shares in the company, valued at $2,325,757.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders sold 72,000 shares of company stock worth $1,591,360. Corporate insiders own 31.03% of the company's stock.

Institutional Trading of UiPath

Institutional investors have recently modified their holdings of the business. Mark Sheptoff Financial Planning LLC bought a new stake in shares of UiPath in the fourth quarter worth $25,000. HighMark Wealth Management LLC bought a new stake in UiPath during the fourth quarter valued at $27,000. Cypress Capital Management LLC WY bought a new stake in UiPath during the fourth quarter valued at $29,000. GAMMA Investing LLC bought a new stake in UiPath during the fourth quarter valued at $36,000. Finally, FNY Investment Advisers LLC bought a new stake in UiPath during the fourth quarter valued at $40,000. Institutional investors own 62.50% of the company's stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.